Literature DB >> 9605954

Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: the MIB-1 labeling index is the most effective parameter.

Y Saito1, Y Matsuzaki, M Doi, T Sugitani, T Chiba, M Abei, J Shoda, N Tanaka.   

Abstract

The aim of this study was to clarify whether histological parameters reflected tumor aggressiveness in n class="Species">patients with hepatocellular carcinoma (HCC). The tumor volume doubling times (TVDTs) of 21 HCCs, less than 3 cm in diameter at the start of the observation period, were calculated in 21 patients in whom the natural progression of the lesion was observed by ultrasonography. Paraffin-embedded sections were prepared from samples obtained by ultrasound-guided fine-needle liver biopsy at the end of the observation period. The histological parameters examined were the MIB-1 labeling index (LI), for which we performed immunohistochemical staining with the MIB-1 monoclonal antibody, using an antigen retrieval method; the nucleo-cytoplasmic (N/C ratio), cellularity, and the nuclear form factor (NFF), were calculated with an imaging analyzer. We performed multiple regression analysis for estimating the growth of small HCCs. With the N/C ratio (0.154 +/- 0.068; mean +/- SD), cellularity (453 +/- 21.8 cells/10(4) microm2), NFF (1.150 +/- 0.096), and degree of HCC differentiation as independent variables, only the MIB-1 LI (11.8 +/- 6.1%) showed a significant correlation with TVDT (207.5 +/- 162.6 days) (r = -0.658; P < 0.05). Compared to the conventional indices of histological atypism tested, i.e., N/C ratio, cellularity NFF, and degree of HCC differentiation, only MIB-1 LI was significantly correlated with small HCC growth rate. The MIB-1 LI may therefore be a simple and useful index of tumor aggressiveness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605954     DOI: 10.1007/s005350050075

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  6 in total

1.  Estimating Tumor Growth Rates In Vivo.

Authors:  Anne Talkington; Rick Durrett
Journal:  Bull Math Biol       Date:  2015-10       Impact factor: 1.758

2.  Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.

Authors:  H Kirimlioglu; I Dvorchick; K Ruppert; S Finkelstein; J W Marsh; S Iwatsuki; A Bonham; B Carr; M Nalesnik; G Michalopoulos; T Starzl; J Fung; A Demetris
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

Review 3.  Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Authors:  An Tang; Mustafa R Bashir; Michael T Corwin; Irene Cruite; Christoph F Dietrich; Richard K G Do; Eric C Ehman; Kathryn J Fowler; Hero K Hussain; Reena C Jha; Adib R Karam; Adrija Mamidipalli; Robert M Marks; Donald G Mitchell; Tara A Morgan; Michael A Ohliger; Amol Shah; Kim-Nhien Vu; Claude B Sirlin
Journal:  Radiology       Date:  2017-11-21       Impact factor: 11.105

4.  Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.

Authors:  Piyush Nathani; Purva Gopal; Nicole Rich; Adam Yopp; Takeshi Yokoo; Binu John; Jorge Marrero; Neehar Parikh; Amit G Singal
Journal:  Gut       Date:  2020-05-12       Impact factor: 23.059

Review 5.  CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?

Authors:  Cosmin Caraiani; Bianca Boca; Vlad Bura; Zeno Sparchez; Yi Dong; Christoph Dietrich
Journal:  Biology (Basel)       Date:  2021-05-06

6.  Analysis of inter-patient variations in tumour growth rate.

Authors:  Esmaeil Mehrara; Eva Forssell-Aronsson
Journal:  Theor Biol Med Model       Date:  2014-05-20       Impact factor: 2.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.